Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FWGL5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,643
Award facts
- Contract value 100% obligated
- $28,642.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $28,642.72 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen 2 mL injections. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by December 10, 2025. The contract supports DLA's medical supply chain operations, with performance executed from the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical prime vendor vehicle running through December 2026 that authorizes the company to supply a broad range of medications, vaccines, and medical supplies globally to support military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards covering diverse therapeutic areas including specialty medications, generic drugs, and medical devices. The DLA's Pharmaceutical Prime Vendor Global Program is transitioning to Generation V contracts with plans for multiple regional awards involving at least three contractors, positioning AmerisourceBergen Drug Corp to continue serving federal healthcare customers including the Defense Health Agency and U.S. Coast Guard through this flexible contracting vehicle.
Quick answers
Who was awarded contract SPE2DR26FWGL5?
SPE2DR26FWGL5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FWGL5 worth?
The government has obligated $28,643 on SPE2DR26FWGL5.
Is contract SPE2DR26FWGL5 an order under another contract?
Yes. SPE2DR26FWGL5 is a delivery order under SPE2DR25D3009, an indefinite delivery contract.
Was contract SPE2DR26FWGL5 competed?
The extent of competition for SPE2DR26FWGL5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award